Portfolio Design Labs LLC Purchases 6,978 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Portfolio Design Labs LLC lifted its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 31.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,313 shares of the company's stock after buying an additional 6,978 shares during the period. Portfolio Design Labs LLC's holdings in Church & Dwight were worth $3,069,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CHD. YANKCOM Partnership purchased a new position in shares of Church & Dwight in the fourth quarter worth $25,000. Capital Performance Advisors LLP purchased a new position in shares of Church & Dwight during the third quarter worth approximately $27,000. Ashton Thomas Securities LLC purchased a new stake in Church & Dwight in the third quarter worth about $28,000. Versant Capital Management Inc increased its holdings in shares of Church & Dwight by 224.4% in the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock valued at $28,000 after acquiring an additional 184 shares during the period. Finally, Strategic Financial Concepts LLC purchased a new stake in Church & Dwight during the fourth quarter valued at approximately $39,000. Institutional investors own 86.60% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CHD shares. Deutsche Bank Aktiengesellschaft boosted their price target on Church & Dwight from $114.00 to $115.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Truist Financial boosted their price objective on Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Monday, February 3rd. JPMorgan Chase & Co. increased their price objective on shares of Church & Dwight from $99.00 to $107.00 and gave the stock an "underweight" rating in a research report on Thursday, January 16th. TD Cowen upped their price target on Church & Dwight from $114.00 to $117.00 and gave the stock a "buy" rating in a report on Monday, November 4th. Finally, Royal Bank of Canada reissued a "sector perform" rating and set a $105.00 price objective on shares of Church & Dwight in a report on Monday, February 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Church & Dwight presently has a consensus rating of "Hold" and an average price target of $111.53.

Insider Buying and Selling at Church & Dwight

In related news, CAO Joseph James Longo sold 7,780 shares of the business's stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $112.44, for a total transaction of $874,783.20. Following the transaction, the chief accounting officer now directly owns 400 shares of the company's stock, valued at approximately $44,976. The trade was a 95.11 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Read acquired 1,100 shares of the firm's stock in a transaction on Monday, December 16th. The stock was purchased at an average cost of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the acquisition, the executive vice president now owns 2,505 shares in the company, valued at approximately $267,584.10. This represents a 78.29 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 102,422 shares of company stock valued at $11,424,351. Company insiders own 2.00% of the company's stock.

Church & Dwight Stock Down 2.2 %

Shares of NYSE:CHD traded down $2.41 during trading on Friday, reaching $105.12. 1,723,559 shares of the company traded hands, compared to its average volume of 1,640,525. The firm has a market cap of $25.75 billion, a P/E ratio of 44.36, a price-to-earnings-growth ratio of 3.35 and a beta of 0.59. Church & Dwight Co., Inc. has a 1-year low of $96.35 and a 1-year high of $113.50. The firm has a fifty day simple moving average of $105.48 and a 200 day simple moving average of $104.51. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period last year, the firm posted $0.65 EPS. Analysts anticipate that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be paid a dividend of $0.295 per share. The ex-dividend date of this dividend is Friday, February 14th. This is a boost from Church & Dwight's previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.12%. Church & Dwight's payout ratio is 47.68%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.